Home › Compare › PXMD vs DIVO

PXMD vs DIVO: Dividend Comparison 2026

PXMD yields 285714.29% · DIVO yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PXMD wins by $1.734986541242196e+31M in total portfolio value
10 years
PXMD
PXMD
● Live price
285714.29%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.734986541242196e+31M
Annual income
$17,337,928,197,276,910,000,000,000,000,000,000,000.00
Full PXMD calculator →
DIVO
DIVO
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full DIVO calculator →

Portfolio growth — PXMD vs DIVO

📍 PXMD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPXMDDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PXMD + DIVO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PXMD pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PXMD
Annual income on $10K today (after 15% tax)
$24,285,714.29/yr
After 10yr DRIP, annual income (after tax)
$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, PXMD beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PXMD + DIVO for your $10,000?

PXMD: 50%DIVO: 50%
100% DIVO50/50100% PXMD
Portfolio after 10yr
$8.67493270621098e+30M
Annual income
$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr
Blended yield
99.93%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PXMD buys
0
DIVO buys
0
No recent congressional trades found for PXMD or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPXMDDIVO
Forward yield285714.29% ✓4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5% ✓
5-year div CAGR0%5% ✓
Portfolio after 10y$1.734986541242196e+31M$28.0K ✓
Annual income after 10y$17,337,928,197,276,910,000,000,000,000,000,000,000.00 ✓$899.19
Total dividends collected$1.734908400352195e+31M$6.4K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: PXMD vs DIVO ($10,000, DRIP)

YearPXMD PortfolioPXMD Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$28,582,129$28,571,428.57$11,120$420.00+$28.57M → PXMD
2$76,351,353,429$76,320,770,551.21$12,357$458.31+$76351.34M → PXMD
3$190,619,493,207,524$190,537,797,259,355.30$13,721$499.76+$190619493.19M → PXMD
4$444,781,927,427,195,200$444,577,964,569,463,100.00$15,227$544.58+$444781927427.18M → PXMD
5$969,967,353,346,567,200,000$969,491,436,684,220,000,000.00$16,885$593.02+$969967353346567.13M → PXMD
6$1,976,961,629,315,093,000,000,000$1,975,923,764,247,012,300,000,000.00$18,713$645.34+$1976961629315092992.00M → PXMD
7$3,765,923,944,594,039,000,000,000,000$3,763,808,595,650,671,000,000,000,000.00$20,724$701.81+$3.765923944594039e+21M → PXMD
8$6,704,681,437,057,684,000,000,000,000,000$6,700,651,898,436,968,000,000,000,000,000.00$22,938$762.73+$6.704681437057683e+24M → PXMD
9$11,156,275,836,497,016,000,000,000,000,000,000$11,149,101,827,359,364,000,000,000,000,000,000.00$25,372$828.41+$1.1156275836497015e+28M → PXMD
10$17,349,865,412,421,960,000,000,000,000,000,000,000$17,337,928,197,276,910,000,000,000,000,000,000,000.00$28,047$899.19+$1.734986541242196e+31M → PXMD

PXMD vs DIVO: Complete Analysis 2026

PXMD — Stock

PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human african trypanosomiasis. It is also involved in developing PAX-102, an intranasal formulation of suramin for neurologic indications. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC.

Full PXMD Calculator →

DIVO — ETF

DIVO is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in DIVO shares.

Full DIVO Calculator →
📬

Get this PXMD vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PXMD vs SCHDPXMD vs JEPIPXMD vs OPXMD vs KOPXMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.